These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 15159323)
1. Methylated DNA collected by tampons--a new tool to detect endometrial cancer. Fiegl H; Gattringer C; Widschwendter A; Schneitter A; Ramoni A; Sarlay D; Gaugg I; Goebel G; Müller HM; Mueller-Holzner E; Marth C; Widschwendter M Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):882-8. PubMed ID: 15159323 [TBL] [Abstract][Full Text] [Related]
2. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837 [TBL] [Abstract][Full Text] [Related]
4. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682 [TBL] [Abstract][Full Text] [Related]
5. Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers. Zighelboim I; Goodfellow PJ; Schmidt AP; Walls KC; Mallon MA; Mutch DG; Yan PS; Huang TH; Powell MA Clin Cancer Res; 2007 May; 13(10):2882-9. PubMed ID: 17504987 [TBL] [Abstract][Full Text] [Related]
6. Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation. Suehiro Y; Okada T; Okada T; Anno K; Okayama N; Ueno K; Hiura M; Nakamura M; Kondo T; Oga A; Kawauchi S; Hirabayashi K; Numa F; Ito T; Saito T; Sasaki K; Hinoda Y Clin Cancer Res; 2008 Jun; 14(11):3354-61. PubMed ID: 18519763 [TBL] [Abstract][Full Text] [Related]
7. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. Chen WD; Han ZJ; Skoletsky J; Olson J; Sah J; Myeroff L; Platzer P; Lu S; Dawson D; Willis J; Pretlow TP; Lutterbaugh J; Kasturi L; Willson JK; Rao JS; Shuber A; Markowitz SD J Natl Cancer Inst; 2005 Aug; 97(15):1124-32. PubMed ID: 16077070 [TBL] [Abstract][Full Text] [Related]
8. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362 [TBL] [Abstract][Full Text] [Related]
9. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936 [TBL] [Abstract][Full Text] [Related]
10. Prognostic DNA methylation marker in serum of cancer patients. Müller HM; Fiegl H; Widschwendter A; Widschwendter M Ann N Y Acad Sci; 2004 Jun; 1022():44-9. PubMed ID: 15251938 [TBL] [Abstract][Full Text] [Related]
11. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Friedrich MG; Weisenberger DJ; Cheng JC; Chandrasoma S; Siegmund KD; Gonzalgo ML; Toma MI; Huland H; Yoo C; Tsai YC; Nichols PW; Bochner BH; Jones PA; Liang G Clin Cancer Res; 2004 Nov; 10(22):7457-65. PubMed ID: 15569975 [TBL] [Abstract][Full Text] [Related]
12. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer. Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703 [TBL] [Abstract][Full Text] [Related]
13. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens. Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431 [TBL] [Abstract][Full Text] [Related]
14. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment. Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238 [TBL] [Abstract][Full Text] [Related]
15. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757 [TBL] [Abstract][Full Text] [Related]
16. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Yu J; Zhu T; Wang Z; Zhang H; Qian Z; Xu H; Gao B; Wang W; Gu L; Meng J; Wang J; Feng X; Li Y; Yao X; Zhu J Clin Cancer Res; 2007 Dec; 13(24):7296-304. PubMed ID: 18094410 [TBL] [Abstract][Full Text] [Related]
17. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer. Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036 [TBL] [Abstract][Full Text] [Related]
18. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons. Bakkum-Gamez JN; Wentzensen N; Maurer MJ; Hawthorne KM; Voss JS; Kroneman TN; Famuyide AO; Clayton AC; Halling KC; Kerr SE; Cliby WA; Dowdy SC; Kipp BR; Mariani A; Oberg AL; Podratz KC; Shridhar V; Sherman ME Gynecol Oncol; 2015 Apr; 137(1):14-22. PubMed ID: 25677060 [TBL] [Abstract][Full Text] [Related]
19. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783 [TBL] [Abstract][Full Text] [Related]
20. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma. Yang Q; Zage P; Kagan D; Tian Y; Seshadri R; Salwen HR; Liu S; Chlenski A; Cohn SL Clin Cancer Res; 2004 Dec; 10(24):8493-500. PubMed ID: 15623630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]